PA Medical News about Cardiovascular Diseases Homocysteine Primary Prevention

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09

Marti–Carvajal AJ et al. – In this review the authors included eight randomised controlled trials equivalent to 24,210 participants. The authors found no evidence that homocysteine–lowering interventions, in the form of supplements of vitamins B6, B9 or B12 given alone or in combination, at any dosage compared with placebo or standard care, prevents myocardial infarction, stroke, or reduces total mortality in participants at risk or with established cardiovascular disease.

Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Annals of Internal Medicine, 10/07/09 Relevance Score: 93%

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study
Cardiovascular Diabetology, 11/03/09 Relevance Score: 88%

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges
Drugs & Aging, 10/26/09 Relevance Score: 88%

Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
Journal of General Internal Medicine, 10/26/09 Relevance Score: 88%

Preventing heart disease in women
Sexuality, Reproduction & Menopause, 10/08/09 Relevance Score: 88%